The Atlanta Journal-Constitution
Charlie Gard, ailing baby in treatment dispute, dies
Brain-damaged boy loses struggle week before 1st birthday.
LONDON — Charlie Gard, the terminally ill British baby at the center of a legal and ethical battle that attracted the attention of Pope Francis and President Donald Trump, died Friday, one week shy of his first birthday.
Charlie’s parents fought for the right to take him to the United States for an experimental medical treatment for his rare genetic disease, mitochondrial depletion syndrome, which left him brain-damaged and unable to breathe unaided. His case ended up in the courts when doctors opposed the plan, saying the untested therapy wouldn’t help Charlie and might cause him to suffer.
A family spokeswoman, Alison Smith-Squire, confirmed Charlie’s death Friday, a day after a judge ordered that he be taken off a ventilator at the Great Ormond Street Hospital in London and moved to an undisclosed hospice for his final hours.
“Our beautiful little boy has gone, we’re so proud of him,” his mother, Connie Yates, said in a statement.
Charlie was seemingly healthy at birth but soon began to weaken. He was admitted to Great Ormond Street Hospital, Britain’s premier children’s hospital, when he was 2 months old and remained there until almost the end of his life.
His legal case became a flashpoint for debates on the rights of children and parents, on health-care funding, medical interventions, the responsibilities of hospitals and medical workers and the role of the state. It gained international attention last month when Francis and Trump expressed their support for Charlie.
The pope reacted quickly to the news of Charlie’s death, tweeting late Friday “I entrust little Charlie to the Father and pray for his parents and all those who loved him.”
Vice President Mike Pence tweeted “Saddened to hear of the passing of Charlie Gard. Karen & I offer our prayers & condolences to his loving parents during this difficult time.”
Charlie’s parents raised more than $1.7 million to pay for the experimental treatment they believed could prolong his life. But British courts consistently accepted the hospital’s position, ruling that it was in Charlie’s best interests that he be allowed to die.
Under British law, it is common for courts to intervene when parents and doctors
disagree on the treatment of a child. In such cases, the rights of the child take primacy over the parents’ right to decide what’s best for their offspring. The principle applies even in cases where parents have an alternative point of view, such as when religious beliefs prohibit blood transfusions.
Offers of help for Charlie came from Dr. Michio Hirano, a neurology expert at New York’s Columbia Medical Center, and from the Vatican’s Bambino Gesù pediatric hospital. Both said an experimental treatment known as nucleoside therapy had a chance of helping Charlie.
Great Ormond Street Hospital disagreed. It said the proposed treatment had never been tried on someone with Charlie’s condition and no tests had even been done on mice to see whether it would work on a patient like Charlie.